Business Context and Reporting Period
Company: Archimedes Tech SPAC Partners II Co. (ATII)
Reporting Period: Fiscal year ended December 31, 2024 (Inception: June 7, 2024).
Business Model: A Cayman Islands exempted company formed as a "blank check" Special Purpose Acquisition Company (SPAC). The Company has no active operations and was formed solely to effect a merger, share exchange, or asset acquisition with one or more target businesses.
Target Sectors: Artificial intelligence, cloud services, and automotive technology.
Key Subsequent Event: On February 12, 2025, the Company consummated its Initial Public Offering (IPO) and a concurrent private placement.
Key Financial Metrics
| Metric | Value (as of Dec 31, 2024) | Value (Post-IPO Feb 12, 2025) |
|---|---|---|
| Revenue | $0 | $0 (No operating revenue) |
| Net Loss | $(78,700) | N/A |
| Cash & Equivalents | $0 | $231,150,000 (in Trust Account) |
| Total Assets | $429,691 (Deferred offering costs) | $231,150,000 (Trust) + Working Capital |
| Total Liabilities | $483,391 | Includes $8,050,000 deferred underwriting fee |
| Shareholder Deficit | $(53,700) | Positive Equity post-IPO |
| Shares Outstanding | 5,750,000 (Founder Shares) | 29,590,000 (Public + Private + Founder) |
Material Changes vs. Prior Period
The reporting period covers the Company's inception through December 31, 2024. There is no prior comparable period. However, significant changes occurred immediately following the balance sheet date:
- Capitalization: Transitioned from a pre-IPO shell with no cash to a public company with $238.4 million in gross proceeds ($230 million IPO + $8.4 million private placement).
- Liquidity: Moved from a working capital deficit of $483,391 to holding $231,150,000 in a Trust Account.
- Debt: Repaid a $192,033 promissory note to the Sponsor upon IPO closing.
- Liabilities: Incurred a deferred underwriting fee of $8,050,000 payable only upon completion of a business combination.
Guidance, Outlook, and Risks
Outlook and Timeline: The Company has 21 months from the IPO closing (February 12, 2025) to consummate an initial business combination. If unsuccessful, the Company will liquidate and redeem public shares.
Management Commentary: Management intends to use funds from the Trust Account, private placement proceeds, and potential debt/equity financing to complete a transaction. They aim to target businesses with sustainable competitive advantages and high growth potential in the technology sector.
Risks and Contingencies:
- Liquidation Risk: If no business combination is completed within 21 months, public shareholders will receive a pro-rata share of the Trust Account (approx. $10.05 per share), and warrants will expire worthless.
- Trust Account Claims: While the Sponsor has agreed to indemnify the Trust Account against third-party claims (up to $10.05 per share), there is no guarantee the Sponsor has sufficient assets to satisfy this obligation.
- Geopolitical Risk: The filing notes potential adverse impacts from the Russia-Ukraine and Israel-Hamas conflicts on global markets and the ability to secure a target.
- Related Party Conflicts: Officers and directors may have conflicts of interest regarding target selection, particularly if targets are affiliated with them.
Investor Verification Checklist
- Trust Account Balance: Verify the current balance in the Trust Account and any interest earned or withdrawn for taxes.
- Redemption Rights: Confirm the specific terms regarding shareholder redemption rights upon a business combination or liquidation.
- Sponsor Indemnity: Assess the financial strength of Archimedes Tech SPAC Sponsors II LLC to ensure they can cover potential claims against the Trust Account.
- Deferred Fees: Note the $8,050,000 deferred underwriting fee that will reduce net assets available to the combined company upon a successful merger.
- Target Selection: Monitor for any disclosure of a specific target business, as none has been identified as of the filing date.